For the quarter ending 2025-12-31, ESMC made $3,591,447 in revenue. $43,787 in net income. Net profit margin of 1.22%.
| Income Statement | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 |
|---|---|---|---|---|
| Revenues, net | 3,591,447 | 2,675,321 | 2,941,864 | - |
| Cost of product and service sold | 2,035,395 | 1,554,579 | 1,660,163.5 | - |
| Marketing, general and administrative | 1,326,132 | 1,107,395 | 1,181,660 | - |
| Research and development | 131,182 | 216,098 | 228,165.5 | - |
| Total costs and expenses | 3,492,709 | 2,878,072 | 3,150,248 | - |
| Income (loss) from operations | 98,738 | -202,751 | -47,866 | - |
| Other nonoperating income (expense) | -285 | -32,797 | -1,250 | - |
| Interest expense, nonoperating | 776 | 4,304 | 5,119.333 | - |
| Total other (expense) income | -1,061 | -37,101 | -7,476.667 | - |
| Preferred stock dividends, income statement impact | - | - | - | 12,689 |
| Income tax expense (benefit) | 0 | 0 | 0 | - |
| Net (loss) income | 97,677 | -239,852 | -379,751 | 271,472 |
| Less income allocated to convertible preferred stocks | 13,006 | 13,006 | 116,738.5 | - |
| Undistributed earnings (loss) allocated to participating securities, basic | 40,884 | - | -103,873.5 | 123,323 |
| Net income (loss) applicable to common stockholders | 43,787 | -252,858 | -184,903 | 135,460 |
| Earnings (loss) per share, basic | 0.01 | -0.03 | -0.03 | 0.02 |
| Earnings (loss) per share, diluted | 0.01 | -0.03 | -0.03 | 0.02 |
| Weighted average shares - basic | 7,415,329 | 7,415,329 | -14,830,658 | 7,415,329 |
| Weighted average shares - diluted | 14,423,729 | 7,415,329 | -21,410,960 | 14,166,217 |
ESCALON MEDICAL CORP (ESMC)
ESCALON MEDICAL CORP (ESMC)